Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-16010184Phase 4Recruiting
Phase 4, randomised trial of dexmedetomidine in Not applicable (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Early rehabilitation. Started Dec 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-16010184.